Exhibit 99.2

ASML — Summary U.S. GAAP Consolidated Statements of Operations ^1,4

	Three months ended,						Nine months ended,
(in thousands EUR, except per share data)	Sep 30, 2007			Sep 28, 2008			Sep 30, 2007			Sep 28, 2008
Net system sales		843,232			590,723			2,516,425			2,136,296
Net service and field option sales		91,142			105,770			296,842			323,562
Total net sales		934,374			696,493			2,813,267			2,459,858
Cost of sales		549,411			431,062			1,653,220			1,483,334
Gross profit on sales		384,963			265,431			1,160,047			976,524
Research and development costs, net of credits		120,077			130,157			356,829			388,657
Amortization of in process R&D		—			—			23,148			—
Selling, general and administrative costs		56,045			51,933			168,771			165,628
Income from operations		208,841			83,341			611,299			422,239
Interest income		9,527			7,059			27,958			17,633
Income from operations before income taxes		218,368			90,400			639,257			439,872
Provision for income taxes		(52,089	)		(17,106	)		(160,797	)		(29,478	)
Net income		166,279			73,294			478,460			410,394
Basic net income per ordinary share		0.35			0.17			1.01			0.95
Diluted net income per ordinary share		0.35	2,3		0.17	3		1.00	2,3		0.94	3
Number of ordinary shares used in computing per share amounts (in thousands):
Basic		474,557			431,672			472,842			431,498
Diluted		481,724	2,3		434,491	3		479,881	2,3		434,859	3

ASML — Ratios and Other Data ^1,4

	Three months ended,				Nine months ended,
	Sep 30, 2007		Sep 28, 2008		Sep 30, 2007		Sep 28, 2008
Gross profit as a % of net sales		41.2		38.1		41.2		39.7
Income from operations as a % of net sales		22.4		12.0		21.7		17.2
Net income as a % of net sales		17.8		10.5		17.0		16.7
Shareholders’ equity as a % of total assets		35.7		50.3		35.7		50.3
Income taxes as a % of income before income taxes		23.9		18.9		25.2		6.7
Sales of systems total (in units)		59		37		205		126
ASP of systems sales (EUR million)		14.3		16.0		12.3		17.0
Value of backlog systems total (EUR million)		1,769		1,028		1,769		1,028
Backlog systems total (in units)		90		53		90		53
ASP of backlog systems (EUR million)		19.7		19.4		19.7		19.4
Value of bookings systems total (EUR million)		857		498		2,167		1,443
Net bookings total (in units)		40		31		132		90
ASP of bookings systems (EUR million)		21.4		16.1		16.4		16.0
Number of employees		6,403		6,907		6,403		6,907

ASML — Summary U.S. GAAP Consolidated Balance Sheets ^1,4

(in thousands EUR)	Dec 31, 2007		Sep 28, 2008
ASSETS
Cash and cash equivalents		1,271,636		1,312,993
Accounts receivable, net		637,975		574,230
Inventories, net		1,102,210		1,134,039
Deferred tax assets short-term		73,019		82,767
Other current assets		234,529		261,341
Total current assets		3,319,369		3,365,370
Deferred tax assets long-term		141,032		139,351
Other assets		59,991		50,632
Goodwill		128,271		129,238
Other intangible assets, net		38,195		28,846
Property, plant and equipment, net		380,894		503,057
Total assets		4,067,752		4,216,494
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities		1,321,437		1,273,016
Deferred tax and other liabilities		245,415		215,182
Other deferred liabilities		7,936		8,749
Other long-term debt		602,016		596,699
Total liabilities		2,176,804		2,093,646
Shareholders’ equity		1,890,948		2,122,848
Total liabilities and shareholders’ equity		4,067,752		4,216,494

ASML — Summary U.S. GAAP Consolidated Statements of Cash Flows ^1,4

	Three months ended,						Nine months ended,
(in thousands EUR)	Sep 30, 2007			Sep 28, 2008			Sep 30, 2007			Sep 28, 2008
CASH FLOWS FROM OPERATING ACTIVITIES
Net income		166,279			73,294			478,460			410,394
Depreciation and amortization		28,008			29,177			105,527			86,298
Disposals of property, plant and equipment		1,698			1,413			12,572			3,828
Share-based payments		3,675			3,687			10,342			10,362
Change in tax assets and liabilities		(5,306	)		(5,970	)		24,274			(98,283	)
Change in assets and liabilities		(20,024	)		(80,747	)		(10,083	)		5,584
Net cash provided by operating activities		174,330			20,854			621,092			418,183
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property, plant and equipment		(49,676	)		(68,237	)		(125,188	)		(188,711	)
Proceeds from sale of property, plant and equipment		—			—			3,355			—
Purchases of intangible assets		—			(35	)		—			(35	)
Acquisition of subsidiary (net of cash acquired)		—			—			(188,011	)		—
Net cash used in investing activities		(49,676	)		(68,272	)		(309,844	)		(188,746	)
CASH FLOWS FROM FINANCING ACTIVITIES
Purchase of shares in conjunction with conversion rights of bond holders and stock options		—			—			(156,253	)		(87,603	)
Dividend paid		—			(394	)		—			(107,841	)
Net proceeds from issuance of shares and stock options		19,464			1,439			40,505			4,967
Net proceeds from issuance of bonds		—			—			593,790			—
Excess tax benefits from stock options		6,226			(1,943	)		7,062			4,027
Redemption and/or repayment of debt		(1,530	)		(1,280	)		(1,875	)		(1,280	)
Net cash provided by (used in) financing activities		24,160			(2,178	)		483,229			(187,730	)
Net cash flows		148,814			(49,596	)		794,477			41,707
Effect of changes in exchange rates on cash		(2,846	)		1,691			(5,107	)		(350	)
Net increase (decrease) in cash & cash equivalents		145,968			(47,905	)		789,370			41,357

ASML — Quarterly Summary U.S. GAAP Consolidated Statements of Operations^1,4

	Three months ended,
(in millions EUR, except per share data)	Sep 30, 2007			Dec 31, 2007			Mar 30, 2008			Jun 29, 2008		Sep 28, 2008
Net system sales		843.2			834.8			820.0			725.6		590.7
Net service and field option sales		91.2			120.1			99.2			118.6		105.8
Total net sales		934.4			954.9			919.2			844.2		696.5
Cost of sales		549.4			565.3			545.6			506.7		431.1
Gross profit on sales		385.0			389.6			373.6			337.5		265.4
Research and development costs, net of credits		120.1			129.3			128.3			130.2		130.2
Selling, general and administrative costs		56.0			56.9			57.3			56.4		51.9
Income from operations		208.9			203.4			188.0			150.9		83.3
Interest income		9.5			5.5			4.2			6.4		7.1
Income from operations before income taxes		218.4			208.9			192.2			157.3		90.4
Benefit from (provision for) income taxes		(52.1	)		(8.1	)		(47.1	)		34.7		(17.1	)
Net income		166.3			200.8			145.1			192.0		73.3
Basic net income per ordinary share		0.35			0.46			0.34			0.45		0.17
Diluted net income per ordinary share 2,3		0.35			0.45			0.33			0.44		0.17
Number of ordinary shares used in computing per share amounts (in thousands):
Basic		474,557			439,317			431,600			431,221		431,672
Diluted 2,3		481,724			444,569			434,959			434,585		434,491

ASML — Quarterly Summary Ratios and other data ^1,4

	Three months ended,
	Sep 30, 2007		Dec 31, 2007		Mar 30, 2008		Jun 29, 2008			Sep 28, 2008
Gross profit as a % of net sales		41.2		40.8		40.6		40.0			38.1
Income from operations as a % of net sales		22.4		21.3		20.5		17.9			12.0
Net income as a % of net sales		17.8		21.0		15.8		22.7			10.5
Shareholders’ equity as a % of total assets		35.7		46.5		44.5		49.7			50.3
Income taxes as a % of income before income taxes		23.9		3.9		24.5		(22.1	)		18.9
Sales of systems total (in units)		59		55		50		39			37
ASP of system sales (EUR million)		14.3		15.2		16.4		18.6			16.0
Value of backlog systems total (EUR million)		1,769		1,697		1,167		1,106			1,028
Backlog systems total (in units)		90		89		65		59			53
ASP of backlog systems (EUR million)		19.7		19.1		18.0		18.8			19.4
Value of booking systems total (EUR million)		857		803		312		632			498
Net bookings total (in units)		40		54		26		33			31
ASP of bookings systems (EUR million)		21.4		14.9		12.0		19.2			16.1
Number of employees		6,403		6,582		6,765		6,821			6,907

ASML — Summary U.S. GAAP Consolidated Balance Sheets ^1,4

(in millions EUR)	Sep 30, 2007		Dec 31, 2007		Mar 30, 2008		Jun 29, 2008		Sep 28, 2008
ASSETS
Cash and cash equivalents		2,445.2		1,271.6		1,397.1		1,360.9		1,313.0
Accounts receivable, net		611.7		638.0		741.5		516.9		574.2
Inventories, net		1,021.2		1,102.2		1,152.0		1,130.2		1,134.0
Deferred tax assets short-term		131.3		73.0		71.1		69.8		82.8
Other current assets		214.2		234.6		267.6		262.2		261.4
Total current assets		4,423.6		3,319.4		3,629.3		3,340.0		3,365.4
Deferred tax assets long-term		143.5		141.0		135.8		157.7		139.4
Other assets		39.9		60.0		85.7		39.3		50.6
Goodwill		133.4		128.3		119.7		119.8		129.2
Other intangible assets, net		44.2		38.2		32.5		30.1		28.8
Property, plant and equipment, net		343.3		380.9		401.4		458.1		503.1
Total assets		5,127.9		4,067.8		4,404.4		4,145.0		4,216.5
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities		2,391.5		1,321.4		1,562.3		1,247.3		1,273.0
Deferred tax and other liabilities		248.3		245.4		261.5		227.0		215.2
Other deferred liabilities		8.2		8.0		7.1		18.5		8.8
Convertible subordinated debt		44.5		—		—		—		—
Other long-term debt		604.0		602.0		615.3		591.6		596.7
Total liabilities		3,296.5		2,176.8		2,446.2		2,084.4		2,093.7
Shareholders’ equity		1,831.4		1,891.0		1,958.2		2,060.6		2,122.8
Total liabilities and shareholders’ equity		5,127.9		4,067.8		4,404.4		4,145.0		4,216.5

ASML — Summary U.S. GAAP Consolidated Statements of Cash Flows ^1,4

	Three months ended,
	Sep 30,			Dec 31,			Mar 30,			Jun 29,			Sep 28,
(in millions EUR)	2007			2007			2008			2008			2008
CASH FLOWS FROM OPERATING ACTIVITIES
Net income		166.3			200.8			145.1			192.0			73.3
Depreciation and amortization		28.0			29.8			30.6			26.5			29.2
Disposals of property, plant and equipment		1.7			1.6			1.1			1.3			1.4
Share-based payments		3.7			6.2			3.5			3.1			3.7
Change in tax assets and liabilities		(5.3	)		(0.6	)		21.8			(114.1	)		(6.0	)
Change in assets and liabilities		(20.1	)		(157.9	)		65.2			21.2			(80.7	)
Net cash provided by operating activities		174.3			79.9			267.3			130.0			20.9
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property, plant and equipment		(49.7	)		(54.0	)		(55.0	)		(65.5	)		(68.3	)
Proceeds from sale of property, plant and equipment		—			1.7			—			—			—
Net cash used in investing activities		(49.7	)		(52.3	)		(55.0	)		(65.5	)		(68.3	)
CASH FLOWS FROM FINANCING ACTIVITIES
Capital repayment		—			(1,011.9	)		—			—			—
Purchase of shares in conjunction with conversion rights of bond holders and stock options		—			(203.6	)		(87.6	)		—			—
Dividend paid		—			—			—			(107.4	)		(0.4	)
Net proceeds from issuance of shares and stock options		19.5			22.8			3.0			0.5			1.4
Excess tax benefits from stock options		6.2			1.9			—			6.0			(1.9	)
Redemption and/or repayment of debt		(1.5	)		(7.8	)		—			—			(1.3	)
Net cash provided by (used in) financing activities		24.2			(1,198.6	)		(84.6	)		(100.9	)		(2.2	)
Net cash flows		148.8			(1,171.0	)		127.7			(36.4	)		(49.6	)
Effect of changes in exchange rates on cash		(2.8	)		(2.6	)		(2.2	)		0.2			1.7
Net increase (decrease) in cash & cash equivalents		146.0			(1,173.6	)		125.5			(36.2	)		(47.9	)

ASML — Notes to the Summary U.S. GAAP Consolidated Financial Statements

Basis of Presentation

ASML follows accounting principles generally accepted in the United States of America (“U.S. GAAP”). Further disclosures, as required under U.S. GAAP in annual reports, are not included in the summary consolidated financial statements. Unless stated otherwise, the accompanying consolidated financial statements are stated in thousands of euros (‘EUR’).

Principles of consolidation

The consolidated financial statements include the accounts of ASML Holding N.V. and all of its majority-owned subsidiaries. Subsidiaries are all entities over which ASML has the power to govern the financial and operating policies generally accompanying a shareholding of more than one half of the voting rights. All intercompany profits, balances and transactions have been eliminated in the consolidation.

Use of estimates

The preparation of ASML’s consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities on the balance sheet dates and the reported amounts of revenue and expense during the reported periods. Actual results could differ from those estimates.

Recognition of revenues

ASML recognizes revenue when all four revenue recognition criteria are met: persuasive evidence of an arrangement exists; delivery has occurred or services have been rendered; seller’s price to the buyer is fixed or determinable; and collectibility is reasonably assured. At ASML, this policy generally results in revenue recognition from the sale of a system upon shipment. The revenue from the installation of a system is generally recognized upon completion of that installation at the customer site. Each system undergoes, prior to shipment, a “Factory Acceptance Test” in ASML’s clean room facilities, effectively replicating the operating conditions that will be present on the customer’s site, in order to verify whether the system will meet its standard specifications and any additional technical and performance criteria agreed with the customer. A system is shipped, and revenue recognized, only after all specifications are met and customer sign-off is received or waived. Although each system’s performance is re-tested upon installation at the customer’s site, ASML has never failed to successfully complete installation of a system at a customer’s premises.

For arrangements containing multiple elements, the revenue relating to the undelivered elements is deferred at estimated fair value until delivery of these elements. Revenue from installation services and service contracts provided to our customers is initially deferred and is recognized when the installation is completed and, in case of service contracts, over the life of those contracts. Revenue from extended and enhanced warranties is recognized in income on a straight-line basis over the contract period. The costs of providing services under extended and enhanced warranties are recognized when they occur.

ASML — Reconciliation U.S. GAAP — IFRS ^1,4

Net income

	Three months ended,						Nine months ended,
(in thousands EUR)	Sep 30, 2007			Sep 28, 2008			Sep 30, 2007			Sep 28, 2008
Net income under U.S. GAAP		166,279			73,294			478,460			410,394
Share-based payments (see Note 1)		280			(2,492	)		293			(3,009	)
Capitalization of development costs (see Note 2)		9,594			14,867			29,575			55,197
Convertible subordinated notes (see Note 3)		(2,265	)		—			(6,661	)		—
Income taxes (see Note 4)		—			(3,119	)		(7,648	)		(3,081	)
Net income under IFRS		173,888			82,550			494,019			459,501

Shareholders’ equity

	Sep 30,		Dec 31,		Mar 30,			Jun 29,			Sep 28,
(in thousands EUR)	2007		2007		2008			2008			2008
Shareholders’ equity under U.S. GAAP		1,831,438		1,890,948		1,958,159			2,060,575			2,122,848
Share-based payments (see Note 1)		7,126		787		(3,420	)		(3,266	)		(7,904	)
Capitalization of development costs (see Note 2)		120,344		138,424		157,900			176,818			193,780
Convertible subordinated notes (see Note 3)		2,894		—		—			—			—
Income taxes (see Note 4)		—		8,852		9,186			8,478			5,969
Shareholders’ equity under IFRS		1,961,802		2,039,011		2,121,825			2,242,605			2,314,693

Notes to the reconciliation from U.S. GAAP to IFRS

Note 1 Share-based Payments

Under IFRS, ASML applies IFRS 2, “Share-based Payments” beginning from January 1, 2004. In accordance with IFRS 2, ASML records as an expense the fair value of its share-based payments with respect to stock options granted to its employees after November 7, 2002.

Under U.S. GAAP, ASML applies SFAS No. 123(R) “Share-Based Payment” which is a revision of SFAS No.123. SFAS 123(R) requires companies to recognize the cost of employee services received in exchange for awards of equity instruments based upon the grant-date fair value of those instruments.

Note 2 Capitalization of development costs

Under IFRS, ASML applies IAS 38, “Intangible Assets”. In accordance with IAS 38, capitalized development expenditures are amortized over the expected useful life of the related product generally ranging between 2 and 3 years. Amortization starts when the developed product is ready for volume production.

Under U.S. GAAP, ASML applies SFAS No. 2, “Accounting for Research and Development Costs”. In accordance with SFAS No. 2, ASML charges costs relating to research and development to operating expense as incurred.

Note 3 Convertible Subordinated Notes

Under IFRS, ASML applies IAS 32 “Financial instruments: Disclosure and presentation” and IAS 39 “Financial instruments: Recognition and measurement” beginning from January 1, 2005. In accordance with IAS 32 and IAS 39, ASML accounts separately for the equity and liability component of its convertible notes (“Split accounting”). The equity component relates to the grant of a conversion option to shares to the holder of the bond. Split accounting results in additional interest charges.

Under U.S. GAAP, ASML accounts for its convertible bonds as a liability at the principal amount outstanding. As of December 31, 2007 ASML has no Convertible Subordinated Notes outstanding.

Note 4 Income taxes

Under IFRS, ASML applies IAS 12, “Income Taxes” beginning from January 1, 2005. In accordance with IAS 12, unrealized net income resulting from intercompany transactions that is eliminated from the carrying amount of assets on consolidation gives rise to a temporary difference for which deferred taxes must be recognized on consolidation. The deferred taxes are calculated based on the tax rate applicable in the purchaser’s tax jurisdiction.

Under U.S. GAAP, the elimination of unrealized net income from intercompany transactions that are eliminated from the carrying amount of assets on consolidation, give rise to a temporary difference for which prepaid taxes must be recognized on consolidation. Contrary to IFRS, the prepaid taxes under U.S. GAAP are calculated based on the tax rate applicable in the seller’s tax jurisdiction.

“Safe Harbor” Statement under the US Private Securities Litigation Reform Act of 1995: the matters discussed in this document may include forward-looking statements, including statements made about our outlook, realization of backlog, IC unit demand, financial results, average sales price, gross margin and expenses. These forward looking statements are subject to risks and uncertainties including, but not limited to: economic conditions, credit market deterioration on consumer confidence which could affect our customers, product demand and semiconductor equipment industry capacity, worldwide demand and manufacturing capacity utilization for semiconductors (the principal product of our customer base), competitive products and pricing, manufacturing efficiencies, new product development and customer acceptance of new products, ability to enforce patents and protect intellectual property rights, the outcome of intellectual property litigation, availability of raw materials and critical manufacturing equipment, trade environment, changes in exchange rates and other risks indicated in the risk factors included in ASML’s Annual Report on Form 20-F and other filings with the US Securities and Exchange Commission.

1	All quarterly information in this press release is unaudited.
2	The calculation of diluted net income per ordinary share assumes conversion of our Subordinated Notes as such conversions would have a dilutive effect.
3	The calculation of diluted net income per ordinary share assumes the exercise of options issued under ASML stock option plans as such exercises would have a dilutive effect.
4	As of January 1, 2008 ASML accounts for award credits offered to its customers as part of a volume purchase agreement using the deferred revenue model. Until December 31, 2007 the cost accrual method was used. This change in accounting policy was made because the deferred revenue model better reflects the business rationale. In addition the International Financial Reporting Interpretation Committee concludes in interpretation 13 (IFRIC 13 “Customer Loyalty Programmes”) that the deferred revenue model is the appropriate accounting treatment. Comparative figures for 2007 were adjusted to reflect this change in accounting policy. The impact of this change on equity as per January 1, 2007 amounted to EUR 8.1 million (decrease) and on net income for the year 2007 and the first quarter of 2008 amounted to EUR 8.6 million (decrease) and EUR 0.1 million (increase) respectively.